Search Results 111-120 of 16857 for Amphotericin B

  1. Publications - Matthew B. Anastasi, M.D. - Mayo Clinic

    Christopher ZK, Hassebrock JD, Anastasi MB, Economopoulos KJ. Hip Flexor Injuries in the Athlete. Clin Sports Med. 2021 Apr; 40(2):301-310. Epub 2021 Jan 19.

  2. Publications - Forrest B. Linch, M.D. - Mayo Clinic

    Linch FB, Chait JD, Takahashi EA, Spinner RJ, Amrami KK, Bjarnason H, Kalra M. Lumbar radiculopathy after left common iliac vein stent placement.

  3. A Study to Evaluate CTX110 in Subjects with Relapsed or Refractory B-Cell Malignancies - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness CTX110 in subjects with relapsed or refractory B cell malignancies. Participation ...

  4. News - Charles J. Bruce, M.B., Ch.B. - Mayo Clinic

    Charles J. Bruce, M.B., Ch.B. · Cardiologist · Echocardiographer.

  5. Publications - Matthew A. Bartlett, M.B., B.Ch., B.A.O. - Mayo Clinic

    Khambaty M, Silbert RE, Stephenson CR, Bartlett MA, Regan DW, Sanchez JJ, Sundsted KK, Mauck KF. Practice changing updates in perioperative medicine ...

  6. News - Alison J. Bruce, M.B., Ch.B. - Mayo Clinic

    B. Dermatologist. Request an Appointment · Overview · News. News. Print. 2025. (VIDEO) The future of skin allergy testing July 21, 2025, 01:37 p.m. CDT. PST- ...

  7. Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations - Mayo Clinic

    This randomized phase III trial studies how well combination chemotherapy works in treating young patients with newly diagnosed B acute lymphoblastic leukemia ...

  8. Diagnosing Lymphangioleiomyomatosis from Glycoprotein Non-Metastatic Melanoma Protein B - Mayo Clinic

    The purpose of this study is to analyze if levels of glycoprotein non-metastatic melanoma protein B be elevated in patients with LAM.. Participation ...

  9. A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2) - Mayo Clinic

    A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple ...

  10. Publications - Amy B. Kolbe, M.D. - Mayo Clinic

    Brown MJ, Kolbe AB, Hull NC, Hilscher M, Kamath PS, Yalon M, Gu CN, Amawi ADT, Venkatesh SK, Wells ML. Imaging of Fontan-Associated Liver Disease. J Comput ...